Katalog der Deutschen Nationalbibliothek

Neuigkeiten Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00
 
 
 


Ergebnis der Suche nach: "000000000"
im Bestand: Gesamter Bestand

151 - 160 von 652
<< < > >>


Artikel 151 Cost Effectiveness of Herpes Zoster Vaccine in Canada
Enthalten in PharmacoEconomics Bd. 27, 17.9.2012, Nr. 12, date:12.2009: 991-1004
Online Ressource
Artikel 152 Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US
Enthalten in PharmacoEconomics Bd. 28, 23.9.2012, Nr. 1, date:1.2010: 47-60
Online Ressource
Artikel 153 Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis
Enthalten in PharmacoEconomics Bd. 30, 23.12.2012, Nr. 12, date:12.2012: 1157-1171
Online Ressource
Artikel 154 Cost Effectiveness of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder
Enthalten in CNS drugs Bd. 26, 21.12.2012, Nr. 7, date:7.2012: 581-600
Online Ressource
Artikel 155 Cost effectiveness of prostacyclins in pulmonary arterial hypertension
Enthalten in Applied health economics and health policy Bd. 10, 6.8.2012, Nr. 3, date:5.2012: 175-188
Online Ressource
Artikel 156 Cost Effectiveness of Respiratory Syncytial Virus Prophylaxis
Enthalten in PharmacoEconomics Bd. 28, 29.9.2012, Nr. 4, date:4.2010: 279-293
Online Ressource
Artikel 157 Cost Effectiveness of Rituximab for Non-Hodgkin’s Lymphoma
Enthalten in PharmacoEconomics Bd. 30, 23.12.2012, Nr. 7, date:7.2012: 537-549
Online Ressource
Artikel 158 Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma
Enthalten in PharmacoEconomics Bd. 28, 23.9.2012, Nr. 1, date:1.2010: 35-46
Online Ressource
Artikel 159 Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payer’s Perspective
Enthalten in PharmacoEconomics Bd. 30, 11.10.2012, Nr. 2, date:2.2012: 87-101
Online Ressource
Artikel 160 Cost Effectiveness of Saxagliptin and Metformin versus Sulfonylurea and Metformin in the Treatment of Type 2 Diabetes Mellitus in Germany
Enthalten in Clinical drug investigation Bd. 32, 29.8.2012, Nr. 3, date:3.2012: 189-202
Online Ressource


151 - 160 von 652
<< < > >>


E-Mail-IconAdministration